Bacteria
This group explores the development of antibiotics to combat multi-drug-resistant bacteria, a critical concern worldwide for public health
The Immunity and Pathogen Research Division is positioned to address the growing complexity of global health challenges, especially at the crossroads between pandemics like COVID-19, climate change, and the emergence of new infectious diseases. Its role is to offer a holistic approach to exploring, facing, and preventing threats to public health, which range from immune response to the intricate interactions between pathogens and the environment. The division’s mission is to understand the mechanisms of viral and bacterial diseases and those that more intensely affect vulnerable populations, like Chagas disease. To carry out this mission, it has medium and high containment biosafety laboratories (BSL-2 and BSL-3) for handling pathogens that are critical to public health, such as SARS-CoV-2 (Covid), the virus that causes yellow fever, and the Mayaro and Rocio viruses.
Expanding the understanding of diseases, identifying molecular targets for personalized therapies, and translating discoveries into health benefits
Implementing methods for scientific results on the cutting-edge of knowledge, playing a vital role in developing and new experimental approaches and putting them into action
Acting as a catalyst and carrying out complex tasks, transforming scientific knowledge into technologies for Brazilian healthcare